- Home
- ATAI vs FBLA Comparison
ATAI vs FBLA Comparison
Compare ATAI & FBLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAI
- FBLA
- Stock Information
- Founded
- ATAI 2018
- FBLA 1908
- Country
- ATAI Germany
- FBLA United States
- Employees
- ATAI N/A
- FBLA N/A
- Industry
- ATAI Biotechnology: Pharmaceutical Preparations
- FBLA
- Sector
- ATAI Health Care
- FBLA
- Exchange
- ATAI Nasdaq
- FBLA NYSE
- Market Cap
- ATAI 222.3M
- FBLA 247.4M
- IPO Year
- ATAI 2021
- FBLA N/A
- Fundamental
- Price
- ATAI $1.50
- FBLA $11.98
- Analyst Decision
- ATAI Strong Buy
- FBLA
- Analyst Count
- ATAI 4
- FBLA 0
- Target Price
- ATAI $9.00
- FBLA N/A
- AVG Volume (30 Days)
- ATAI 1.9M
- FBLA 149.6K
- Earning Date
- ATAI 11-13-2024
- FBLA 01-01-0001
- Dividend Yield
- ATAI N/A
- FBLA N/A
- EPS Growth
- ATAI N/A
- FBLA N/A
- EPS
- ATAI N/A
- FBLA N/A
- Revenue
- ATAI $331,000.00
- FBLA $79,358,000.00
- Revenue This Year
- ATAI $80.07
- FBLA N/A
- Revenue Next Year
- ATAI N/A
- FBLA N/A
- P/E Ratio
- ATAI N/A
- FBLA N/A
- Revenue Growth
- ATAI N/A
- FBLA 19.62
- 52 Week Low
- ATAI $1.03
- FBLA $10.74
- 52 Week High
- ATAI $2.85
- FBLA $12.74
- Technical
- Relative Strength Index (RSI)
- ATAI 52.34
- FBLA N/A
- Support Level
- ATAI $1.36
- FBLA N/A
- Resistance Level
- ATAI $1.50
- FBLA N/A
- Average True Range (ATR)
- ATAI 0.15
- FBLA 0.00
- MACD
- ATAI -0.00
- FBLA 0.00
- Stochastic Oscillator
- ATAI 41.43
- FBLA 0.00
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.
About FBLA FB BANCORP INC
FB Bancorp Inc is a holding company. It operates through its subsidiary Fidelity Bank. Fidelity business consists primarily of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in primary market areas. Its services also include residential construction loans, commercial real estate loans (which includes commercial mortgage, commercial construction and land development loans), commercial loans (which includes commercial and industrial, small business and other commercial loans not secured by real estate), home equity loans and lines of credit, and consumer loans.